New biomarker and therapeutic target identified for MS
19 june 2025
Researchers from the Netherlands Institute for Neuroscience (NIN), in collaboration with the University of Münster (Germany) and the University of Turku (Finland), have discovered a novel biomarker for severe multiple sclerosis (MS). This research will contribute to our understanding of the molecular processes involved in progressive MS, and may aid in allocation of patients to novel therapies.
Source: Nature Medicine